1333 results about "Resuscitation" patented technology

A physiological measuring system is disclosed that monitors certain physiological parameters of an individual through the use of a body-mounted sensing apparatus. The apparatus is particularly adapted for continuous wear. The system is also adaptable or applicable to calculating derivations of such parameters. A oxygen debt measuring embodiment is directed predicting an outcome in response to injury and illness. The technique allows for closed-loop resuscitation, early identification of illness and early corrective action.

A resuscitation system for use by a rescuer for resuscitating a patient, comprising at least two high-voltage defibrillation electrodes, a first electrical unit comprising circuitry for providing resuscitation prompts to the rescuer, a second electrical unit separate from the first unit and comprising circuitry for providing defibrillation pulses to the electrodes, and circuitry for providing at least one electrical connection between the first and second units. In another aspect, at least two electrical therapy electrodes adapted to be worn by the patient for extended periods of time, circuitry for monitoring the ECG of the patient, an activity sensor adapted to be worn by the patient and capable of providing an output from which the patient's current activity can be estimated, and at least one processor configured for estimating the patient's current activity by analyzing the output of the activity sensor, analyzing the ECG of the patient, and determining whether electrical therapy should be delivered to the electrodes.

A method for assessing CPR performed during at least one resuscitation event includes obtaining a data set during each of the at least one resuscitation events, each data set including data characterizing the performance of chest compressions or ventilations, or both, on the patient during the at least one resuscitation event; processing the data set to determine a value of at least one parameter of the performance; and displaying a graphical representation of the at least one parameter. A graphical representation of a desired value or range of values of the at least one parameter may be displayed in a position for visual comparison with the determined value. A method for presenting information on a sequence of events during a resuscitation event includes: obtaining data on the sequence and timing of chest compression and lung ventilations from a defibrillator; and displaying symbols for chest compressions and lung ventilations in a linear sequence corresponding to the order in which the compressions and ventilations occurred, the linear distance between successive symbols being proportional to the temporal distance between the corresponding actions.

A self-contained transportable life support system for resuscitation, stabilization, and transport of a patient has an environmentally controlled housing for receiving and supporting a patient and a plurality of medical devices disposed within the housing. A control circuit attached to the housing has at least a portion thereof extending to an external surface of the housing for regulating operation of the medical devices and environmental conditions of within the housing in response to monitored life support conditions of the patient.

A system is disclosed wherein patient data, such as an electrocardiogram (“ECG”) signal or a chest impedance measurement signal, collected by a defibrillator device during a resuscitation event is analyzed and processed by a computing device to provide an assessment of CPR administered during the event. The CPR assessment results in one or more CPR figures of merit that relate to temporal characteristics of the CPR relative to the duration of the event. In one embodiment, the CPR figure of merit represents a percentage of the event period during which chest compressions were administered to the patient.

Methods and apparatus are provided for determining a defibrillation treatment protocol in an external defibrillator using a measurement of elapsed time. The present invention provides a defibrillator with a timer function. Upon activation of the defibrillator, an internal timer begins to run. By closely associating the activation of the defibrillator with the onset of the patient's attack, and by making allowances for inherent time differences between these events, the timer provides a measure of the elapsed time between the onset of the patient's emergency and the presentation of the defibrillator at the patient's side. Using this measure of elapsed time, the defibrillator determines an appropriate treatment therapy, such as CPR or defibrillation therapy.

A method for endotracheal intubation allows resuscitation of the patient to continue during intubation. A curved guide having a mask and a ventilation port is inserted into the patient's mouth and upper airway. The patient is initially resuscitated by supplying a flow of air / oxygen through the mask and simultaneously applying cardiac chest compressions. An endotracheal tube is inserted over the distal end of a fiber optic probe. Resuscitation continues without interruption while the fiber optic probe and endotracheal tube are advanced along the guide into the patient's airway, thereby allowing the physician to carefully guide the fiber optic probe and endotracheal tube to a position past the larynx while resuscitation continues.

A connector for resuscitating an infant or neonate is disclosed. The pressure is varied between Peak Inspiratory Pressure (PIP) and Peak End Expiratory Pressure (PEEP) by the occlusion of the PEEP outlet. The PEEP outlet may either allow variable PEEP, by adjustment, or substantially flow independent fixed PEEP using a novel umbrella valve. A duck billed valve is included for suctioning of surfactant delivery during resuscitation. The connector is adapted to one handed use.

A medical resuscitation system includes an external physiological stimulator system module for resuscitating a patient and an external communication system module. The external physiological stimulator and communication system modules are removeably coupled together. The external communication system module can flow a signal between it and an electronic patient information module carried by a patient. The external physiological stimulator system module can resuscitate the patient in response to this signal.

An inflatable resuscitation face mask comprising a top sheet joined to a bottom sheet to form an inflatable pocket which when inflated forms a raised body having an apex and a lower perimeter, wherein inflation means is provided on the mask and an opening at the apex allows air to be administered through the opening to an area underneath the inflated mask.

A respiratory valve apparatus with a housing having a upper entry port and an opposite endotracheal tube connection port, along with a resuscitation bag connection port and an respirator connection port. The housing has an inner chamber. A reciprocating valve assembly fits within a chamber and slides between two positions whereby the entry, endotracheal, and respirator ports are open in one position, and the entry, endotracheal, and resuscitation ports are open in the second position. The valve assembly is a component of a surgical kit including a resuscitation bag, an endotracheal tube, and a suction catheter. A guide fixture can be attached to the entry port to help steer a catheter through the apparatus. An elongated protective bag can be sealably attached around the catheter to prevent external contact with the catheter surfaces when it is withdrawn.

The invention relates to novel hemoglobin compositions, particularly novel recombinant mutant hemoglobin compositions, which eliminate or substantially reduce 1) the creation of heart lesions, 2) gastrointestinal discomfort, 3) pressor effects, and 4) endotoxin hypersensitivity associated with the administration of extracellular hemoglobin compositions in various therapeutic applications. Applications described include treatments for anemia, head injury, hemorrhage or hypovolemia, ischemia, cachexia, sickle cell crisis and stroke; enhancing cancer treatments; stimulating hematopoiesis; improving repair of physically damaged tissues; alleviating cardiogenic shock; and shock resuscitation.

A self-inflating resuscitation system formed from a self-inflating resuscitation bag and an exhalation indicator. In particular, the self-inflating resuscitation bag provides an exhalation indicator, which may be an audio or visual indicator, or both. The exhalation indicator enables a caregiver to more accurately determine whether a patient is being ventilated, unlike prior art self-inflating resuscitation bags, and helps to detect esophageal intubation in intubated patients or gastric trapping of gas in non-intubated patients undergoing positive pressure ventilation. In general, the device may be interposed between any source of positive pressure ventilation and any airway device to monitor exhalation as an indicator of adequacy of ventilation.

A fuel cell system includes fuel cells forming a fuel cell stack, having a fuel passage and an oxidant passage. A purge valve is coupled to the fuel passage to exhaust contaminants, and a controller is coupled to temporarily increase the oxidant stream flow rate through the oxidant passage, and to temporarily open the fuel purge valve, if a voltage across a pair of fuel cells is less than a defined threshold voltage. In this resuscitation step, the oxidant flow rate can be temporarily increased by increasing a duty cycle of an air compressor by approximately 50% for a duration of between approximately 5 to 10 seconds. The controller can further shut down fuel cell operation if a voltage across a pair of fuel cells is less than a defined threshold voltage in an inter-resuscitation period immediately following the resuscitation step.

The invention relates to a capsule for forcedly improving the immunity, which is a capsule formulation prepared by traditional Chinese medicines of parasites detoxifying and destroying type, heat dry dampness clearing, detoxifying and blood cooling type, cough and asthma relieving and phlegm reducing type, temperature cooling and exterior relieving type, kidney warming and yang enhancing type, health building type, resolving damp with aromatics and blood enriching type, qi invigorating type, spleen and stomach strengthening and interior warming type, invigorating blood circulation by removing blood stasis type, liver soothing and qi regulating type, yin tonifying and converging type, digestion helping type, liver clearing, vision helping and resuscitation inducing type, deswelling and pain stopping type, heart nourishing as well as fever reducing and fire purging type according to a certain preparation method. The capsule has the functions as follows: forcedly improving the immunity, clearing away heat and toxic material, detoxifying and destroying parasites, soothing the liver and regulating qi, invigorating blood circulation by removing blood stasis, building health, invigorating qi and enriching blood, regulating qi and stopping pain, inducing diuresis and excreting dampness, eliminating phlegm, relieving cough and asthma, warming kidney and enhancing yang, invigorating the spleen and stomach and the like. The capsule has effects for various headaches, dizzy and neurasthenia, and various intestinal tract diseases, abdominal pains and abdominal distension, and various waist and leg pains and various tumors, and can cure diseases when in ill, build body when not in ill, and can achieve the goal of healthy and long life if the long-term or discontinuous taking is carried out.

The invention provides a cell freezing medium. The cell freezing medium comprises acylated epsilon polylysine, polyhydric alcohols and equilibration buffer. According to the cell freezing medium disclosed by the invention, the polyhydric alcohols and acylated epsilon polylysine replace toxic dimethyl sulfoxide so as to serve as cryoprotective agents, so that damage to cells in the freezing resuscitation process is reduced, and the cell survival rate is improved. The invention further provides a method for performing freezing resuscitation on cells by utilizing the cell freezing medium and application of the method for freezing stem cells and immune cells. The method is simple and feasible to operate and is suitable for large-scale clinical application of cell therapy, and great convenienceis brought to clinical application of the cell freezing technology.

A method of applying electrotherapy to the heart of a patient includes positioning electrodes in communication with the heart of the patient; monitoring the patient's heart to determine if its fibrillating; and providing a first signal with a current generator to the heart through the electrodes in response to an indication that the heart is fibrillating. The first stimulus signal reduces the amount of fibrillation.

The invention provides a cryopreservation method and a resuscitation method of neural stem cells (NSCs), and provides a cryopreserved NSC solution and a resuscitated NSC solution with cell survival rates higher than 90%. The solutions are prepared with the methods provided by the invention. Also, the invention provides a cryopreservation medium and a resuscitation medium used in the NSC cryopreservation method and resuscitation method.

The invention comprises of a device that allows health care providers to position the body of a patient for progression of labor, for assistance in fetal resuscitation, and for other medical procedures. The device has inflatable chambers that assist the labor and delivery health care provider in turning a patient onto her right or left side while laying in bed. An inflatable positioning pad is used to further assist with the turning of a patient and / or with the shifting of a patient toward the head or the foot of the bed as needed. This device and method will allow turning to be done frequently, rapidly and safely, especially in pregnant patients with epidurals, that are overweight, or that otherwise have difficulty moving on their own.

The invention relates to the field of cell culture, in particular to cell cryopreservation liquid, application thereof and a cryopreservation method of megakaryocyte progenitor cells. The cell cryopreservation liquid comprises DMSO, fetal calf serum, dextran, trehalose and albumin. By means of the cell cryopreservation liquid, the cytoactive of the megakaryocyte progenitor cells can be well maintained during the cryopreservation period, and damage to cells in the cryopreservation and resuscitation processes is lowered. According to the cell cryopreservation liquid, application thereof and the cryopreservation method of the megakaryocyte progenitor cells, the cryopreservation and temperature reduction processes are softer, the cells are stored in liquid nitrogen after the temperature reduction process is conducted, the influence on the cytoactive is small, and damage to the cells in the cryopreservation process is lowered. It is indicated by experiments that the vigour of the resuscitated cells can reach 94% one month after the megakaryocyte progenitor cells are cryopreservated in the cryopreservation liquid, and multiplication activity is good, and the cell cryopreservation liquid is significantly superior to the prior art.

The present invention provides compositions and methods for protecting tissues and organs from damage during transplantation or from acute ischemia due to, e.g., injury or surgery. The compositions protect the tissue or organ from acidosis, oxidative damage, ischemia and repurfusion injury while the organ is isolated from the normal circulation or receives inadequate arterial flow.

A gas blender with auxiliary mixed gas outlet for mixing a primary gas, generally air, and a secondary gas, generally oxygen, to obtain a mixed gas having several controlled characteristics. The gas blender may be incorporated into a Continuous Positive Airway Pressure (CPAP) device. The gas blender controls the mixing to produce the mixed gas having a predetermined mixture setpoint, generally an oxygen percentage, and a predetermined control setpoint, generally a pressure setpoint or flow rate setpoint. The gas blender provides an auxiliary mixed gas source for use by an auxiliary piece of equipment such as a nebulizer or resuscitation bag. The gas blender includes a primary gas inlet passageway, a secondary gas inlet passageway, a gas mixing apparatus, a mixed gas distribution passageway with an auxiliary mixed gas outlet, a gas sensor, a delivery sensor, a mixed gas delivery control valve, a mixed gas controlled passageway, and a controller.